NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Bill Elliott Bill Elliott @BillElliott.165627
Dec 2, 2020 Bullish $4.18 X 0
JS JS Pro
Oct 19, 2020 $5.02 -9.06% $5.52 X 90.94% 0
iHustle84 iHustle84 Pro
Oct 19, 2020 $4.76 -13.77% $5.52 X 86.23% 0
Oct 19, 2020 Bearish $5.52 X 0
JS JS Pro
Aug 28, 2020 $3.66 -13.88% $4.25 X 86.12% 0
iHustle84 iHustle84 Pro
Aug 28, 2020 $3.10 -27.06% $4.25 X 72.94% 0
2poJeff 2poJeff Pro
Aug 28, 2020 $4.01 -5.65% $4.25 X 94.35% 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 21, 2020 $4.27 +2.64% $4.16 X 97.36% 0
JS JS Pro
Aug 21, 2020 $4.21 +1.20% $4.16 X 98.80% 2
Aug 21, 2020 $4.37 +5.05% $4.16 X 94.95% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE